Study identified five genes, including two novel genes, associated with Lewy Body dementia. Researchers also found the genetic profiles of patients with LBD showed higher chances of also suffering from Alzheimer's and Parkinson's disease than other age-matched control subjects.
Researchers are developing new psychological therapies and using cutting edge techniques to help treat symptoms of psychosis in dementia.
New research aims to improve the disposal of toxic proteins in the fight against neurodegenerative diseases.
Combining PET neuroimaging with a specific intravenous radioactive compound allows researchers to distinguish Lewy Body Dementia from Parkinson's disease and Alzheimer's in brain scans.
Increased ceramide levels in the brain may be a unique feature of all types of Lewy body dementias, including LBD associated with Parkinson's disease.
A new study reports on how the clinical profiles of Lewy body dementia differ from Alzhiemer's or Parkinson's disease.
Alterations in the cerebral neural network could function as a biomarker for the early diagnosis of mild cognitive impairment, Alzheimer's disease, and Lewy Body dementia.
A new study reveals information about life expectancy for those with Parkinson's and other synucleinopathies.
A new study reveals Hispanic Americans diagnosed with Alzheimer's disease tend to survive significantly longer with the condition than people from other ethnoracial groups.
A common misconception is that Alzheimer's disease and dementia are the same thing. Alzheimer's disease is simply one form of dementia. Researchers from Texas A&M describe how Alzheimer's and other forms of dementia impact the lives of both patients and their families, and provide new insights into minimizing the risks of developing neurodegenerative conditions.
Researchers report those who have had appendectomies have a reduced risk of developing Parkinson's disease. A new study reveals the appendix acts as a reservoir for proteins associated with the neurodegenerative disease.
A new method of examining blood plasma allowed researchers to identify specific chemical bonds within the blood. The new technique allowed researchers to accurately distinguish between Alzheimer's disease and Lewy body dementia, thus reducing cases of misdiagnosis.